balsalazide FDA Link Generic

a mesalamine 5-aminosalicylate prodrug; 99% of ingested drug remains intact through the stomach and is delivered to and activated in the colon; used for inflammatory bowel disease, ulcerative colitis and radiation-induced proctosigmoiditis but avoided in patients with known hypersensitivity reaction to salicylates or mesalamine; structure in first source

Also Known As:

Colazal; 5- (carboxyethylcarbamoyl- 4- phenylazo)salicylic acid; BX 661A; BX661A; Colazide; balsalazide disodium; balsalazine; Benzoic acid, 5- ((4- (((2- carboxyethyl)amino)carbonyl)phenyl)azo)- 2- hydroxy- , disodium salt

Pharmalogical Action Categories:

D000894 - Anti-Inflammatory Agents, Non-Steroidal
D005765 - Gastrointestinal Agents

Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Benzene Derivatives: 17
        Phenols: 702
        Hydroxybenzoates: 18
        Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
        balsalazide: 78
        Benzoates: 430
        Hydroxybenzoates: 18
        Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
        balsalazide: 78
        Aminobenzoates: 1
        meta-Aminobenzoates
        Mesalamine: 2762
        balsalazide: 78
- Carboxylic Acids: 986
  - Hydroxy Acids: 97
    - Hydroxybenzoates: 18
      - Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
        balsalazide: 78
  - Carbocyclic Acids
    - Benzoates: 430
      - Hydroxybenzoates: 18
        Salicylates: 2354
        Aminosalicylic Acids: 6
        Mesalamine: 2762
        balsalazide: 78
      - Aminobenzoates: 1
        meta-Aminobenzoates
        Mesalamine: 2762
        balsalazide: 78
- Hydrazines: 388
  - Phenylhydrazines: 2
    - balsalazide: 78

J W Brandes Selected Research

J W Brandes Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure